Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Ogsiveo, nirogacestat, Date of authorisation: 14/08/2025, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Date of authorisation: 17/07/2025, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Cinacalcet Accordpharma, cinacalcet, Date of authorisation: 03/04/2020, Revision: 6, Status: Authorised

European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes

European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure

Pre-submission interactions form for marketing authorisation application

Pre-submission interactions model pilot

Pre-authorisation guidance